In the article by Selvaraj et al, “Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial,” which appeared in the November 2018 issue of the journal (Circ Heart Fail. 2018;11:e005288), a correction was needed.

In Table 3, in the row containing data for eGFR (Absent), the confidence interval is incorrect: “0.72 (0.52, 1.54), P=0.05” should read “0.72 (0.52, 1.00), P=0.05”.

The authors regret this error.

These corrections have been made to the current version of the article, which is available at https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.118.005288.

在Selvaraj等人的文章中，“蛋白尿的预后价值和螺内酯对保留射血分数对心力衰竭的影响：TOPCAT试验”发表在该杂志的2018年11月号上（Circ Heart Fail。2018; 11：e005288 ），则需要进行更正。

在表3中，在包含eGFR（不存在）数据的行中，置信区间不正确：“ 0.72（0.52，1.54），P = 0.05”应读为“ 0.72（0.52，1.00），P = 0.05”。

作者对此错误表示遗憾。

对本文的当前版本进行了更正，可从https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.118.005288获得。